Advances in the Management of Age-Related Macular Degeneration: Current Insights and Future Directions

Ali Muhye Aldeen Rasheed

doi:10.51699/cajmns.v7i1.3011

Ali Muhye Aldeen Rasheed Department of Ophthalmology, College of Medicine, Kirkuk University, Kirkuk, Iraq

DOI: https://doi.org/10.51699/cajmns.v7i1.3011

Keywords: Age-related macular degeneration, anti-VEGF, Visual acuity, Patient compliance, Quality of life

Abstract

Among ocular diseases, AMD is one of the major causes leading to visual loss in elderly population and has high rate of impact on quality of life. Effective treatment is challenging, even as therapeutic options evolve while The objective of the present study is to assess our progress in AMD management focusing on the efficacy, visual acuity results, compliance data, and overall health-related quality of life and collected in our study One hundred and six patients with a diagnosis of AMD were reviewed after 1 year in various hospitals in Iraq between 2024 and 2025. We evaluated VA, treatment methods, and complications as well as QOL in questionnaires and eye checkups as well as Visual acuity gain post treatment was substantial with 37.7% gaining to 20/20. The most frequent were anti-VEGF injections (56.6%). Compliance was very good, 56.6 percent were absolutely compliant. Satisfaction among patients was high, with the majority achieving significant gains in the quality of their life so finally Progress in the treatment of AMD, and especially with anti-VEGF therapy, has been reflected in better visual outcome and patient satisfaction. Patient education and compliance are critical to optimizing treatment results.

References

D. M. Gohdes, A. Balamurugan, B. A. Larsen, and C. Maylahn, "Age-Related Eye Diseases: An Emerging Challenge for Public Health Professionals," Prev. Chronic Dis., vol. 2, A17, 2005. [Online]. Available: https://www.cdc.gov/pcd/issues/2005/oct/05_0084.htm.

J. V. Forrester, A. D. Dick, P. G. McMenamin, F. Roberts, and E. Pearlman, The Eye. Amsterdam, The Netherlands: Elsevier, 2016, pp. 157–268.e4. [Google Scholar].

K. Cholkar, S. R. Dasari, D. Pal, and A. K. Mitra, "Ocular Transporters and Receptors: Their Role in Drug Delivery," Eye: Anatomy, Physiology and Barriers to Drug Delivery, Amsterdam, The Netherlands: Elsevier Ltd., 2013, pp. 1–36. [Google Scholar].

M. M. Moschos, E. Nitoda, I. P. Chatziralli, and C. A. Demopoulos, "Age-Related Macular Degeneration: Pathogenesis, Genetic Background, and the Role of Nutritional Supplements," J. Chem., vol. 2014, Article ID 317536, 2014. [Online]. Available: https://doi.org/10.1155/2014/317536.

"Eye Care, Vision Impairment and Blindness," World Health Organization, Apr. 25, 2022. [Online]. Available: https://www.who.int/health-topics/blindness-and-vision-loss#tab=tab_1.

K. J. Cheng, C. M. Hsieh, K. Nepali, and J. P. Liou, "Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye," J. Med. Chem., vol. 63, pp. 10533–10593, 2020. [Online]. Available: https://doi.org/10.1021/acs.jmedchem.9b01033.

L. Wang, M. E. Clark, D. K. Crossman, et al., "Abundant Lipid and Protein Components of Drusen," PloS One, vol. 5, Article e10329, 2010. [Online]. Available: https://doi.org/10.1371/journal.pone.0010329.

Y. Wang, M. Wang, X. Zhang, et al., "The Association Between the Lipid Levels in Blood and Risk of Age-Related Macular Degeneration," Nutrients, vol. 8, Article E663, 2016. [Online]. Available: https://doi.org/10.3390/nu8100663.

J. L. Yip, A. P. Khawaja, M. P. Chan, et al., "Cross Sectional and Longitudinal Associations Between Cardiovascular Risk Factors and Age-Related Macular Degeneration in the EPIC-Norfolk Eye Study," PloS One, vol. 10, Article e0132565, 2015. [Online]. Available: https://doi.org/10.1371/journal.pone.0132565.

J. S. L. Tan, P. Mitchell, W. Smith, and J. J. Wang, "Cardiovascular Risk Factors and the Long-Term Incidence of Age-Related Macular Degeneration: The Blue Mountains Eye Study," Ophthalmology, vol. 114, pp. 1143–50, 2007. [Online]. Available: https://doi.org/10.1016/j.ophtha.2006.09.033.

M. G. Erke, G. Bertelsen, T. Peto, et al., "Cardiovascular Risk Factors Associated with Age-Related Macular Degeneration: The Tromsø Study," Acta Ophthalmol. (Copenh.), vol. 92, pp. 662–9, 2014. [Online]. Available: https://doi.org/10.1111/aos.12346.

Z. P. Vassilev, A. Ruigómez, M. Soriano-Gabarró, and L. A. García Rodríguez, "Diabetes, Cardiovascular Morbidity, and Risk of Age-Related Macular Degeneration in a Primary Care Population," Invest. Ophthalmol. Vis. Sci., vol. 56, pp. 1585–92, 2015. [Online]. Available: https://doi.org/10.1167/iovs.14-16271.

L. G. Fritsche, et al., "Seven New Loci Associated with Age-Related Macular Degeneration," Nat. Genet., vol. 45, no. 4, pp. 433–439, 2013. [Online]. Available: https://doi.org/10.1038/ng.2578.

Age-Related Eye Disease Study Research Group, "A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8," Arch. Ophthalmol., vol. 119, no. 10, pp. 1417–1436, 2001. [Online]. Available: https://doi.org/10.1001/archopht.119.10.1417.

E. Y. Chew, et al., "Lutein/Zeaxanthin for the Treatment of Age-Related Cataract: AREDS2 Randomized Trial Report No. 4," JAMA Ophthalmol., vol. 131, no. 7, pp. 843–850, 2013. [Online]. Available: https://doi.org/10.1001/jamaophthalmol.2013.4412.

W. G. Christen, D. A. Schaumberg, R. J. Glynn, and J. E. Buring, "Dietary ω-3 Fatty Acid and Fish Intake and Incident Age-Related Macular Degeneration in Women," Arch. Ophthalmol., vol. 129, no. 7, pp. 921–929, 2011. [Online]. Available: https://doi.org/10.1001/archophthalmol.2011.34.

M. Schleicher, K. Weikel, C. Garber, and A. Taylor, "Diminishing Risk for Age-Related Macular Degeneration with Nutrition: A Current View," Nutrients, vol. 5, no. 7, pp. 2405–2456, 2013. [Online]. Available: https://doi.org/10.3390/nu5072405.

M. Boulton, "Ageing of the Retina and Retinal Pigment Epithelium," in Age-Related Macular Degeneration, F. G. Holz, D. Pauleikhoff, R. F. Spaide, and A. C. Bird, Eds., Heidelberg, Germany: Springer, 2013, pp. 45–63. [Google Scholar].

M. Suter, et al., "Age-Related Macular Degeneration. The Lipofuscin Component N-Retinyl-N-Retinylidene Ethanolamine Detaches Proapoptotic Proteins from Mitochondria and Induces Apoptosis in Mammalian Retinal Pigment Epithelial Cells," J. Biol. Chem., vol. 275, no. 50, pp. 39625–39630, 2000. [Online]. Available: https://doi.org/10.1074/jbc.M007049200.

A. Ly, L. Nivison-Smith, N. Assaad, and M. Kalloniatis, "Infrared Reflectance Imaging in Age-Related Macular Degeneration," Ophthalmic Physiol. Opt., vol. 36, pp. 303–316, 2016. [Online]. Available: https://doi.org/10.1111/opo.12283.

C. Bowes Rickman, S. Farsiu, C. A. Toth, and M. Klingeborn, "Dry Age-Related Macular Degeneration: Mechanisms, Therapeutic Targets, and Imaging," Investig. Ophthalmol. Vis. Sci., vol. 54, pp. ORSF68–ORSF80, 2013. [Online]. Available: https://doi.org/10.1167/iovs.13-12757